Biomimetic Therapeutics, Inc. (BMTI) Income Statement

Click line-items for a historical chart and %

Product sales	359.56K
Royalty income	72.51K
Sublicense fee income	244.79K
Total revenues	688.66K
Cost of sales (exclusive of depreciation and amortization shown separately below)	129.34K
Research and development	1.93M
General and administrative
Depreciation and capital lease amortization	233.35K
Patent license fee amortization	11.23K
Total costs and expenses	5.3M
Loss from operations	-4.61M
Interest expense, net
Investment income, net	15.78K
Gain (loss) on disposal of equipment and other transactions
Loss before income taxes	-4.6M
Income taxes	0
Net loss	-4.6M
Basic and diluted net loss per share	-0.16
Weighted average shares used to compute basic and diluted net loss per share

Entities mentioned with BMTI

View All Entities